Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in HAEMONETICS CORP MASS
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 135,697 shares of HAE (HAEMONETICS CORP MASS), worth $7.6M as of 2026-Q1. The position was increased (+3.1% shares). HAE represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$7.6M
Current Shares
135,697
Total Value Change
-$3.3M
Total Shares Change
+3,931
Other major holders of HAE: BNP PARIBAS FINANCIAL MARKETS
Increased |
| 135,697 |
+3.1% |
| $7.6M |
| 0.0% |
| $65.63 |
28 |
| 2025-Q4 | Decreased | 131,559 | -0.3% | $10.5M | 0.0% | $80.98 | 0 |
| 2025-Q3 | Decreased | 131,966 | -38.3% | $6.4M | 0.0% | $48.12 | 0 |
| 2025-Q2 | Increased | 213,909 | +37.0% | $16M | 0.0% | $73.80 | 37 |
| 2025-Q1 | Increased | 156,138 | +6.2% | $9.9M | 0.0% | $63.19 | 29 |
| 2024-Q4 | Increased | 147,087 | +14.8% | $11.5M | 0.0% | $76.60 | 32 |
| 2024-Q3 | Decreased | 128,123 | -2.8% | $10.3M | 0.0% | $79.80 | 0 |
| 2024-Q2 | Increased | 131,766 | +92.1% | $10.9M | 0.0% | $82.73 | 44 |